Alpha mangostin inhibits proliferation, migration, and invasion of human breast cancer cells via STAT3 inhibition
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00159816%3A_____%2F23%3A00079715" target="_blank" >RIV/00159816:_____/23:00079715 - isvavai.cz</a>
Alternative codes found
RIV/00216224:14110/23:00133682
Result on the web
<a href="https://www.sciencedirect.com/science/article/pii/S2667394023000035?via%3Dihub" target="_blank" >https://www.sciencedirect.com/science/article/pii/S2667394023000035?via%3Dihub</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.adcanc.2023.100089" target="_blank" >10.1016/j.adcanc.2023.100089</a>
Alternative languages
Result language
angličtina
Original language name
Alpha mangostin inhibits proliferation, migration, and invasion of human breast cancer cells via STAT3 inhibition
Original language description
Signal Transducer and Activator of Transcription 3 (STAT3) is an identified critical protein associated with the progression of cancer. Alpha mangostin (alpha-M), a powerful dietary xanthone found to have anti-cancer properties against various cancers. However, the precise mechanism of its anti-cancer activity is not fully understood. Therefore, the current work hypothesized that targeting STAT3 with alpha-M inhibits the migration, invasion, and proliferation of breast cancer cells. Firstly, we evaluated the binding affinity of alpha-M/STAT3 complex using molecular dynamic simulations (MDS) and further we determined the likely underlying mechanism of STAT3 through in-vitro experiments. alpha-M treatment affected the levels of STAT3 phosphorylation, hnRNP-A1, PKM2, and EMT markers. alpha-M stimulation in breast cancer cells also resulted in suppressed migratory and invasive behaviour. More importantly, the treatment also affected the Ki67 and BrdU positive cells. In summary, we found the anti-migratory and anti-proliferative actions of alpha-M in breast cancer cells via STAT3 inhibition. Also, the study significantly adds a new nutraceutical for therapeutic intervention of invasive breast cancer.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30204 - Oncology
Result continuities
Project
<a href="/en/project/LX22NPO5107" target="_blank" >LX22NPO5107: National institute for Neurological Research</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2023
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
ADVANCES IN CANCER BIOLOGY-METASTASIS
ISSN
2667-3940
e-ISSN
2667-3940
Volume of the periodical
7
Issue of the periodical within the volume
JUL 2023
Country of publishing house
NL - THE KINGDOM OF THE NETHERLANDS
Number of pages
11
Pages from-to
100089
UT code for WoS article
001136029700001
EID of the result in the Scopus database
—